Skip to main content
SpringerLink
Log in

Risk of spontaneous abortion with adefovir dipivoxil or entecavir

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Yang R, et al. Adverse Events During Pregnancy Associated With Entecavir and Adefovir: New Insights From a Real-World Analysis of Cases Reported to FDA Adverse Event Reporting System Frontiers in Pharmacology : 3 Jan 2022. Available from: URL: https://doi.org/10.3389/fphar.2021.772768

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risk of spontaneous abortion with adefovir dipivoxil or entecavir. Reactions Weekly 1891, 11 (2022). https://doi.org/10.1007/s40278-022-09263-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-09263-6

Search

Navigation